Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Cash & Current Investments (2020 - 2025)

Cellebrite DI (CLBT) has 5 years of Cash & Current Investments data on record, last reported at $285.5 million in Q4 2025.

  • For Q4 2025, Cash & Current Investments fell 17.34% year-over-year to $285.5 million; the TTM value through Dec 2025 reached $285.5 million, down 17.34%, while the annual FY2025 figure was $285.5 million, 17.34% down from the prior year.
  • Cash & Current Investments reached $285.5 million in Q4 2025 per CLBT's latest filing, down from $345.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $345.4 million in Q4 2024 and bottomed at $132.3 million in Q4 2022.
  • Average Cash & Current Investments over 4 years is $247.9 million, with a median of $256.9 million recorded in 2023.
  • Peak YoY movement for Cash & Current Investments: skyrocketed 72.51% in 2023, then decreased 17.34% in 2025.
  • A 4-year view of Cash & Current Investments shows it stood at $132.3 million in 2022, then skyrocketed by 72.51% to $228.2 million in 2023, then skyrocketed by 51.35% to $345.4 million in 2024, then fell by 17.34% to $285.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Current Investments were $285.5 million in Q4 2025, $345.4 million in Q4 2024, and $228.2 million in Q4 2023.